[go: up one dir, main page]

NO940524D0 - Condensed 5-membered heterocycles, process for their preparation, and drugs containing these compounds - Google Patents

Condensed 5-membered heterocycles, process for their preparation, and drugs containing these compounds

Info

Publication number
NO940524D0
NO940524D0 NO940524A NO940524A NO940524D0 NO 940524 D0 NO940524 D0 NO 940524D0 NO 940524 A NO940524 A NO 940524A NO 940524 A NO940524 A NO 940524A NO 940524 D0 NO940524 D0 NO 940524D0
Authority
NO
Norway
Prior art keywords
condensed
compounds
preparation
membered heterocycles
drugs containing
Prior art date
Application number
NO940524A
Other languages
Norwegian (no)
Other versions
NO940524L (en
Inventor
Volkhard Austel
Helmut Pieper
Frank Himmelsbach
Gunter Linz
Thomas Muller
Hans Weisenberger
Brian Guth
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO940524D0 publication Critical patent/NO940524D0/en
Publication of NO940524L publication Critical patent/NO940524L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO940524A 1993-02-16 1994-02-15 Condensed 5-membered heterocycles, process for their preparation, and drugs containing these compounds NO940524D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4304650A DE4304650A1 (en) 1993-02-16 1993-02-16 Condensed 5-membered heterocycles, processes for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO940524D0 true NO940524D0 (en) 1994-02-15
NO940524L NO940524L (en) 1994-08-17

Family

ID=6480585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940524A NO940524D0 (en) 1993-02-16 1994-02-15 Condensed 5-membered heterocycles, process for their preparation, and drugs containing these compounds

Country Status (10)

Country Link
EP (1) EP0611660A3 (en)
JP (1) JPH072839A (en)
AU (1) AU5513094A (en)
CA (1) CA2115737A1 (en)
DE (1) DE4304650A1 (en)
FI (1) FI940697A7 (en)
IL (1) IL108648A0 (en)
NO (1) NO940524D0 (en)
NZ (1) NZ250879A (en)
ZA (1) ZA941021B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751647B1 (en) * 1996-07-25 1998-09-11 Synthelabo BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS
TR200001079T2 (en) 1997-10-20 2000-07-21 F.Hoffmann-La Roche Ag Bicyclic kinase inhibitors.
EA005974B1 (en) 2001-02-23 2005-08-25 Мерк Энд Ко., Инк. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
EA200400595A1 (en) 2001-11-09 2004-10-28 Бёрингер Ингельхайм Фармасьютиклз, Инк. BENZIMIDAZOLY, USED AS PROTEKINKINASE INHIBITORS
WO2004014905A1 (en) 2002-08-08 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
ES2524803T3 (en) 2002-12-19 2014-12-12 The Scripps Research Institute Compositions and methods to stabilize transthyretin and inhibit the abnormal folding of transthyretin
EP1479676A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Benzimidazole-derivatives as factor xa inhibitors
US7741341B2 (en) 2003-05-19 2010-06-22 Sanofi-Aventis Deutschland Gmbh Benzimidazole-derivatives as factor Xa inhibitors
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
US20050261365A1 (en) 2004-05-20 2005-11-24 The Scripps Research Institute Transthyretin stabilization
WO2009086077A2 (en) * 2007-12-21 2009-07-09 Endacea, Inc. A1 adenosine receptor antagonists
KR20140054231A (en) 2011-09-16 2014-05-08 화이자 인코포레이티드 Solid forms of a transthyretin dissociation inhibitor
EP2956450B1 (en) 2013-02-14 2018-07-25 Technische Universität München Hydroxyindalpine derivatives and their medical use
US9233961B2 (en) 2013-03-15 2016-01-12 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US9296754B2 (en) 2013-03-15 2016-03-29 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US9186361B2 (en) 2013-03-15 2015-11-17 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
DK2970303T6 (en) * 2013-03-15 2018-10-08 Hydra Biosciences Inc SUBSTITUTED XANTHINES AND PROCEDURES FOR USING IT
TN2016000253A1 (en) 2013-12-19 2017-10-06 Novartis Ag [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis.
JP6403865B2 (en) * 2014-07-03 2018-10-10 シャンハイ インスティテュート オブ ファーマシューティカル インダストリー Method for producing dabigatran etexilate intermediate and intermediate compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208367B (en) 1987-07-09 1991-07-03 Alcatel Business Systems Franking machine
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
DE4129603A1 (en) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS
DE4214245A1 (en) * 1992-04-30 1993-11-04 Thomae Gmbh Dr K TRITIUM-MARKED FIBRINOGEN RECEPTOR ANTAGONISTS, THEIR USE AND METHOD FOR THEIR PRODUCTION
ATE140225T1 (en) * 1992-04-28 1996-07-15 Thomae Gmbh Dr K TRITIUM LABELED FIBRINOGEN RECEPTOR ANTAGONISTS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
EP0611660A3 (en) 1994-09-14
FI940697A7 (en) 1994-08-17
NZ250879A (en) 1995-09-26
DE4304650A1 (en) 1994-08-18
ZA941021B (en) 1995-08-15
FI940697A0 (en) 1994-02-15
CA2115737A1 (en) 1994-08-17
JPH072839A (en) 1995-01-06
AU5513094A (en) 1994-08-18
NO940524L (en) 1994-08-17
IL108648A0 (en) 1994-05-30
EP0611660A2 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
FI940378A0 (en) 5-membered heterocycles, process for their preparation and drugs containing these compounds
DK0612741T3 (en) Cyclic derivatives, drugs containing these compounds and processes for their preparation
NO940524D0 (en) Condensed 5-membered heterocycles, process for their preparation, and drugs containing these compounds
NO933248D0 (en) Cyclic urea derivatives, drugs containing these compounds, and processes for their preparation
DK0502314T3 (en) Benzimidazoles, drugs containing these compounds and methods for their preparation
FI923366A7 (en) 5-membered heterocycles, a method for their preparation and pharmaceuticals containing these compounds
FI923960A7 (en) 5-membered heterocycles, a method for their preparation and pharmaceuticals containing these compounds
DK1156049T3 (en) Substituted heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them
NO924027D0 (en) Heterobia Age Derivatives, Drugs Containing These Compounds, and Procedures for Their Preparation
NO308738B1 (en) Bicyclically condensed pyridines, drugs containing them and use of the compounds for the preparation of drugs
FI954105A7 (en) New 4-aminopyridines, their preparation method and drugs containing these compounds
NO934501D0 (en) Carboxylic acid derivatives, drugs containing these compounds, and processes for their preparation
NO984084D0 (en) 4-Amino-pyrimidine derivatives, medicaments containing these compounds, their use and method of preparation thereof
FI943687L (en) New 11-benzaldoxime estradiene derivatives, methods for their preparation and pharmaceuticals containing these compounds
NO932120D0 (en) BIFENYL DERIVATIVES, PHARMACEUTICALS CONTAINING THESE, AND PROCEDURE FOR THEIR PREPARATION
DK231687D0 (en) HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE, AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS
NO305398B1 (en) Thiosubstituted nitrogen-containing heterocyclic phosphonate compounds, and uses thereof
NO932636L (en) Benzimidazoles, drugs containing these compounds, and methods for their preparation
DK162491D0 (en) Heterocyclic compounds, their preparation and pharmaceutical preparations containing the compounds
DK166279C (en) 3,4-DIHYDRO-2H-BENZOOEBAAPYRANDER DERIVATIVES, THEIR PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS
DK0838469T3 (en) 10,13,15-Trioxatricyclo (9.2.1 9.6) -pentadecanone derivatives, process for their preparation, and drugs containing these compounds
DK102990D0 (en) THIENO-TRIAZOLODIAZEPINE DERIVATIVES, PROCEDURES FOR THE PREPARATION OF SUCH COMPOUNDS, AND MEDICINES CONTAINING THESE
NO930796D0 (en) GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
NO934633D0 (en) Condensed heterocyclic compounds, their preparation and use
NO933558D0 (en) BENZIMIDAZOLES, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, AND PROCEDURE FOR THEIR PREPARATION